As long as a cure remains elusive, the fight against cancer will hold a prominent place in medicine. And rightly so. Perhaps one of the greatest medical challenges in oncology care is treating a cancer whose origin (where the cancer started) is unknown or uncertain after initial diagnostic work-up. In the oncology world, the most difficult of these cancers to diagnose are known as cancer of unknown primary (or CUP for short). Cancer patients diagnosed with CUP often have delays in treatment, suboptimal treatment options, and poor prognoses. CancerTYPE ID is a validated molecular cancer classifier, developed by Biotheranostics, Inc. (San Diego, CA), to help Oncologists and Pathologists provide an accurate diagnosis for metastatic cancer patients with these unknown or uncertain cancer types.
You may also like
Every year, millions of patients, families and caregivers are impacted by cancer in the United...MoreAccess Health 28253
Do you know your family’s history of cancer? If you have an inherited hereditary cancer...MoreJose Rodriguez 5064